SLF:NYSESun Life Financial Inc. Analysis
Data as of 2026-08-31 - not real-time
$78.17
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
At $78.17, Sun Life Financial Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has lost 3.1%. With RSI at 39.3 the momentum picture is approaching oversold, alongside a bearish MACD signal. Watch $78.08 as support and $83.01 as the nearer resistance level.
Multiples put this in fair territory: 18.4 times earnings against the sector's 16.9. The average analyst target implies 17.8% below today's level. Revenue is growing at 7.5% on a 9.5% profit margin. The 3.52% dividend yield looks stretched against payout coverage.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 15.4%, a beta of 0.36 and a maximum drawdown of 11.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Multiples put this in fair territory: 18.4 times earnings against the sector's 16.9. The average analyst target implies 17.8% below today's level. Revenue is growing at 7.5% on a 9.5% profit margin. The 3.52% dividend yield looks stretched against payout coverage.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 15.4%, a beta of 0.36 and a maximum drawdown of 11.0%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 3/10.
Top Market Events
Sun Life Financial TSX:SLF is back in focus after reporting second quarter 2026 results, updating its dividend and...Sun Life Financial Inc SLF delivers robust Q2 2026 with record Canada earnings, 13% underlying EPS growth, and improved...Sun Life SLF doesn't possess the right combination of the two key ingredients for a likely earnings beat in its...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 69.35
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 18.4 versus sector average of 16.9
- Dividend yield of 3.52% looks stretched against payout coverage
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 18.4 versus sector average of 16.9
- Dividend yield of 3.52% looks stretched against payout coverage
- Analyst targets imply -17.8% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth7.50%
Profit Margin9.52%
P/E Ratio18.4
ROE13.09%
ROA0.78%
Debt/Equity58.01
P/B Ratio2.6
Op. Cash Flow$4.7B
Free Cash Flow$-13761250304
Industry P/E16.9
Technical Analysis
TrendBullish
RSI39.3
Support$78.08
Resistance$83.01
MA 20$80.28
MA 50$80.27
MA 200$69.35
MACDBearish
VolumeIncreasing
Fear & Greed Index94.32
Valuation
Fair Value$287.50
Target Price$64.27
Upside/Downside-17.79%
GradeFair
TypeBlend
Dividend Yield3.52%
Risk Assessment
Beta0.36
Volatility15.36%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.